Conclusion
A method for analysis of acylcarnitines in blood at physiological concentrations has been developed. Preliminary results from umbilical cord blood and neonatal blood spotted onto Guthrie cards are encouraging. This method will detect up to at least eight inherited metabolic disorders which exhibit diagnostic acylcarnitine profiles, including medium-chain acyl-CoA dehydrogenase deficiency. The speed and simplicity of the method permit automation with existing technology, and could enable routine neonatal screening to be carried out in an efficient and cost-effective manner.
References
Millington, D. S., Norwood, D. L., Kodo, N., Roe, C. R. and Inoue, F. Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood and tissue.Anal. Biochem. 180 (1989) 331–339
Roe, C. R., Millington, D. S. and Maltby, D. A. Diagnostic and therapeutic implications of acylcarnitine profiling in organic acidurias associated with carnitine insufficiency. In Borum, P. R. (ed.),Clinical Aspects of Human Carnitine Deficiency, Pergamon Press, New York; 1986, pp 97–107
Valkner, K. O. and Bieber, L. L. Short-chain acylcarnitines of human blood and urine.Biochem. Med. 28 (1982) 197–203.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Millington, D.S., Kodo, N., Norwood, D.L. et al. Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 13, 321–324 (1990). https://doi.org/10.1007/BF01799385
Issue Date:
DOI: https://doi.org/10.1007/BF01799385